ITI-333

N/A

Report date: 2023/10/20 15:06:47
NME

Base Information

Drug NameITI-333
Drug Alias NameITI-333
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsOpioid receptors agonistsSerotonin 2a (5-HT2a) receptor antagonists
TargetsDopamine D1 receptorOpioid receptorsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsMood DisordersOpioid-Related DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntra-Cellular Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntra-Cellular Therapies Inc
Inactive CompaniesN/A
Active IndicationsMood DisordersOpioid-Related DisordersPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A